China · Delayed Price · Currency is CNY Chase Science Statistics
Total Valuation
Chase Science has a market cap or net worth of CNY 3.64 billion. The enterprise value is 2.89 billion.
| Market Cap | 3.64B |
| Enterprise Value | 2.89B |
Important Dates
The last earnings date was Monday, April 27, 2026.
| Earnings Date | Apr 27, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Chase Science has 202.96 million shares outstanding. The number of shares has decreased by -20.95% in one year.
| Current Share Class | 202.96M |
| Shares Outstanding | 202.96M |
| Shares Change (YoY) | -20.95% |
| Shares Change (QoQ) | -15.42% |
| Owned by Insiders (%) | 50.19% |
| Owned by Institutions (%) | 0.73% |
| Float | 87.98M |
Valuation Ratios
The trailing PE ratio is 108.23.
| PE Ratio | 108.23 |
| Forward PE | n/a |
| PS Ratio | 14.20 |
| PB Ratio | 2.75 |
| P/TBV Ratio | 2.84 |
| P/FCF Ratio | 567.13 |
| P/OCF Ratio | 531.31 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 157.33, with an EV/FCF ratio of 449.85.
| EV / Earnings | 96.46 |
| EV / Sales | 11.26 |
| EV / EBITDA | 157.33 |
| EV / EBIT | 185.03 |
| EV / FCF | 449.85 |
Financial Position
The company has a current ratio of 16.91, with a Debt / Equity ratio of 0.00.
| Current Ratio | 16.91 |
| Quick Ratio | 11.47 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | 0.21 |
| Debt / FCF | 0.61 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 2.46% and return on invested capital (ROIC) is 2.34%.
| Return on Equity (ROE) | 2.46% |
| Return on Assets (ROA) | 0.70% |
| Return on Invested Capital (ROIC) | 2.34% |
| Return on Capital Employed (ROCE) | 1.17% |
| Weighted Average Cost of Capital (WACC) | 7.03% |
| Revenue Per Employee | 775,250 |
| Profits Per Employee | 90,509 |
| Employee Count | 331 |
| Asset Turnover | 0.18 |
| Inventory Turnover | 4.96 |
Taxes
In the past 12 months, Chase Science has paid 3.49 million in taxes.
| Income Tax | 3.49M |
| Effective Tax Rate | 9.79% |
Stock Price Statistics
The stock price has decreased by -19.03% in the last 52 weeks. The beta is 0.51, so Chase Science's price volatility has been lower than the market average.
| Beta (5Y) | 0.51 |
| 52-Week Price Change | -19.03% |
| 50-Day Moving Average | 20.71 |
| 200-Day Moving Average | 24.58 |
| Relative Strength Index (RSI) | 32.44 |
| Average Volume (20 Days) | 3,494,087 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Chase Science had revenue of CNY 256.61 million and earned 29.96 million in profits. Earnings per share was 0.17.
| Revenue | 256.61M |
| Gross Profit | 97.27M |
| Operating Income | 15.62M |
| Pretax Income | 35.60M |
| Net Income | 29.96M |
| EBITDA | 16.77M |
| EBIT | 15.62M |
| Earnings Per Share (EPS) | 0.17 |
Balance Sheet
The company has 788.28 million in cash and 3.89 million in debt, with a net cash position of 784.38 million or 3.86 per share.
| Cash & Cash Equivalents | 788.28M |
| Total Debt | 3.89M |
| Net Cash | 784.38M |
| Net Cash Per Share | 3.86 |
| Equity (Book Value) | 1.32B |
| Book Value Per Share | 6.25 |
| Working Capital | 1.29B |
Cash Flow
In the last 12 months, operating cash flow was 6.86 million and capital expenditures -433,118, giving a free cash flow of 6.42 million.
| Operating Cash Flow | 6.86M |
| Capital Expenditures | -433,118 |
| Depreciation & Amortization | 1.16M |
| Net Borrowing | -1.34M |
| Free Cash Flow | 6.42M |
| FCF Per Share | 0.03 |
Margins
Gross margin is 37.91%, with operating and profit margins of 6.09% and 11.67%.
| Gross Margin | 37.91% |
| Operating Margin | 6.09% |
| Pretax Margin | 13.87% |
| Profit Margin | 11.67% |
| EBITDA Margin | 6.54% |
| EBIT Margin | 6.09% |
| FCF Margin | 2.50% |
Dividends & Yields
This stock pays an annual dividend of 0.13, which amounts to a dividend yield of 0.72%.
| Dividend Per Share | 0.13 |
| Dividend Yield | 0.72% |
| Dividend Growth (YoY) | -20.63% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 89.11% |
| Buyback Yield | 20.95% |
| Shareholder Yield | 21.66% |
| Earnings Yield | 0.82% |
| FCF Yield | 0.18% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on June 9, 2022. It was a forward split with a ratio of 1.5.
| Last Split Date | Jun 9, 2022 |
| Split Type | Forward |
| Split Ratio | 1.5 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 4 |